概述

  • 产品名称Anti-EPO抗体
    参阅全部 EPO 一抗
  • 描述
    兔多克隆抗体to EPO
  • 特异性No crossreactivity to a cytokine test panel (ELISA).
  • 经测试应用适用于: ELISA, WB, Neutralising, IHC-Pmore details
  • 种属反应性
    与反应: Human
  • 免疫原

    CHO cell derived recombinant human EPO.

性能

应用

Our Abpromise guarantee covers the use of ab30545 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
ELISA Use a concentration of 0.5 - 1 µg/ml. Detection limit is ~1ng/well.
WB Use a concentration of 1 - 2 µg/ml. Predicted molecular weight: 21 kDa.
Neutralising Use a concentration of 1 - 3 µg/ml. 1 hour at 37°C. The suggested antibody concentration can detect 0.3 units/ml recombinant human EPO in cell line TF1.
IHC-P Use at an assay dependent concentration.

靶标

  • 相关性Human erythropoietin is member of the EPO/TPO family and encodes a secreted, glycosylated cytokine hormone composed of four alpha helical bundles. The protein is found in the plasma and regulates red cell production by promoting erythroid differentiation and initiating hemoglobin synthesis. This protein also has neuroprotective activity against a variety of potential brain injuries and antiapoptotic functions in several tissue types. It is produced by kidney or liver of adult mammals and by liver of fetal or neonatal mammals.
  • 细胞定位Secreted
  • 数据库链接
  • 别名
    • EP antibody
    • EPO alpha antibody
    • EPO antibody
    • Epoetin antibody
    • Erythropoetin antibody
    • Erythropoietin precursor antibody
    • MVCD2 antibody
    see all

Anti-EPO antibody (ab30545)参考文献

This product has been referenced in:
  • Rades D  et al. Prognostic impact of erythropoietin expression and erythropoietin receptor expression on locoregional control and survival of patients irradiated for stage II/III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 80:499-505 (2011). IHC-P ; Human . Read more (PubMed: 20646855) »
  • Medana IM  et al. Erythropoietin and its receptors in the brainstem of adults with fatal falciparum malaria. Malar J 8:261 (2009). IHC-P ; Human . Read more (PubMed: 19930602) »

See all 2 Publications for this product

Product Wall

Thank you for kindly letting us know your protocol details and results as this enables us to closely monitor the quality of our products

We would be pleased to arrange a replacement product free of charge. I am forwarding these details on to...

Read More

Thank you for contacting us and for sharing your results with us.

I have happy to hear that we were able to improve your results for the sELISA using EPO1 and EPO2.

I am sorry to hear that ab30545 is still not performing even with t...

Read More

Thank you for taking time to complete our questionnaire. I am sorry to hear that these antibodies are not providing satisfactory results.

The details provided will enable us to investigate this case and will provide us with vital information...

Read More

Thank you for contacting us.

I am sorry to hear that you are experiencing difficulties with one of our products. We take product complaints very seriously, and investigate every product that we feel may not be performing correctly.

I ...

Read More

Thank you for your response. Unfortunately, none of these antibodies (EPO) have been specifically tested in IP. You may be interested in our testing discount scheme. The Terms and Conditions of this offer can be found at: www.abcam.com/collaboration...

Read More

Thank you for your enquiry and your interest. There are different alternative names for erythropoietin, please see some listed below: EP antibody EPO alpha antibody EPO antibody Epoetin antibody Ery...

Read More

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"